Ayala Pharmaceuticals Probability of Future OTC Stock Price Finishing Over 1.38
| ADXSDelisted Stock | USD 1.38 0.34 32.69% |
Ayala |
Ayala Pharmaceuticals Target Price Odds to finish over 1.38
The tendency of Ayala OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.38 | 90 days | 1.38 | about 1.99 |
Based on a normal probability distribution, the odds of Ayala Pharmaceuticals to move above the current price in 90 days from now is about 1.99 (This Ayala Pharmaceuticals probability density function shows the probability of Ayala OTC Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Ayala Pharmaceuticals has a beta of 0.57. This suggests as returns on the market go up, Ayala Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Ayala Pharmaceuticals will be expected to be much smaller as well. Moreover Ayala Pharmaceuticals has an alpha of 1.7864, implying that it can generate a 1.79 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Ayala Pharmaceuticals Price Density |
| Price |
Predictive Modules for Ayala Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ayala Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ayala Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ayala Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Ayala Pharmaceuticals is not an exception. The market had few large corrections towards the Ayala Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ayala Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ayala Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.79 | |
β | Beta against Dow Jones | 0.57 | |
σ | Overall volatility | 0.18 | |
Ir | Information ratio | 0.09 |
Ayala Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ayala Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ayala Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Ayala Pharmaceuticals is not yet fully synchronised with the market data | |
| Ayala Pharmaceuticals may become a speculative penny stock | |
| Ayala Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 250 K. Net Loss for the year was (16.24 M) with profit before overhead, payroll, taxes, and interest of 3.24 M. | |
| Ayala Pharmaceuticals currently holds about 28.15 M in cash with (16.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 15.5, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Ayala Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ayala OTC Stock often depends not only on the future outlook of the current and potential Ayala Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ayala Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Shares Percent Shares Out | 2.19% | |
| Short Percent Of Float | 2.19% | |
| Float Shares | 1.82M | |
| Shares Short Prior Month | 44.99k | |
| Average Daily Volume Last 10 Day | 1.63k | |
| Average Daily Volume In Three Month | 2.98k | |
| Date Short Interest | 15th of December 2021 |
Ayala Pharmaceuticals Technical Analysis
Ayala Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Ayala OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ayala Pharmaceuticals. In general, you should focus on analyzing Ayala OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Ayala Pharmaceuticals Predictive Forecast Models
Ayala Pharmaceuticals' time-series forecasting models is one of many Ayala Pharmaceuticals' otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Ayala Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Ayala Pharmaceuticals
Checking the ongoing alerts about Ayala Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Ayala Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Ayala Pharmaceuticals is not yet fully synchronised with the market data | |
| Ayala Pharmaceuticals may become a speculative penny stock | |
| Ayala Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 250 K. Net Loss for the year was (16.24 M) with profit before overhead, payroll, taxes, and interest of 3.24 M. | |
| Ayala Pharmaceuticals currently holds about 28.15 M in cash with (16.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 15.5, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Ayala OTC Stock
If you are still planning to invest in Ayala Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ayala Pharmaceuticals' history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |